These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3502537)

  • 1. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
    Musatti CC; Yasaka K; Santos LM
    Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI; Bostick-Bruton F
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 5. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
    Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal regulation in the production of IL2 in Hodgkin's disease].
    Marchiol C; Kaplan C; Chouaib S; Janvier M; Ferme C; Muller JY; Fradelizi D
    C R Acad Sci III; 1985; 301(6):283-8. PubMed ID: 3928105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
    Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.
    Ford RJ; Tsao J; Kouttab NM; Sahasrabuddhe CG; Mehta SR
    Blood; 1984 Aug; 64(2):386-92. PubMed ID: 6611180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
    Engleman EG; Benike C; Hoppe RT; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
    Damle RN; Advani SH; Gangal SG
    Cancer Immunol Immunother; 1991; 34(3):205-10. PubMed ID: 1756538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and signal transduction of T-cell antigen receptor (TCR)/CD3 complexes on fresh or in vitro expanded T lymphocytes from patients with Hodgkin's and non-Hodgkin's lymphomas.
    Rubin B; Martin EP; Arnaud J; Delsol G; Plesner T; Ratsimbazafy A; Llobera R; Holm B; Mariame B
    Scand J Immunol; 1997 Jun; 45(6):715-25. PubMed ID: 9201313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
    Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
    Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
    J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal phytohemagglutinin-induced T-cell proliferative responses in Hodgkin's disease.
    Schulof RS; Lacher MJ; Gupta S
    Blood; 1981 Mar; 57(3):607-13. PubMed ID: 6970056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.